HURA NASDAQ
TuHURA Biosciences, Inc.
1W: -9.1%
1M: -8.6%
3M: -19.1%
YTD: +154.8%
1Y: -24.8%
3Y: -54.5%
5Y: -95.7%
$1.91
-0.07 (-3.54%)
Weekly Expected Move ±5.8%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships11
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-08-03
Earliest Filing
2025-12-10
Latest Filing
partner: 5
target: 3
investor: 2
acquirer: 1
Counterparties (Filed by HURA)
11 relationshipsCompanies named in HURA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| K&V Investment One LLC | — | investor | Purchaser in the registered direct offering of common stock and warrants. | 2025-12-10 | View |
| H.C. Wainwright & Co., LLC | — | partner | Exclusive lead placement agent for the offering. | 2025-12-10 | View |
| Rodman & Renshaw LLC | — | partner | Co-placement agent for the offering. | 2025-12-10 | View |
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for at-the-market offering of common stock | 2025-11-04 | View |
| Kineta, Inc. | — | target | Target company in a merger agreement with TuHURA Biosciences, Inc. | 2025-05-07 | View |
| Kineta, Inc. | — | target | Target company in a merger agreement with TuHURA Biosciences, Inc. | 2024-12-12 | View |
| Kintara Therapeutics, Inc. | KTRA | acquirer | Acquiring company entering into a merger agreement. | 2024-04-03 | View |
| TuHURA Biosciences, Inc. | HURA | target | Target company being acquired in the merger. | 2024-04-03 | View |
| Kayak Mergeco, Inc. | — | partner | Wholly-owned subsidiary of Kintara used as the merger vehicle. | 2024-04-03 | View |
| A.G.P./Alliance Global Partners | — | partner | Sales Agent for the Company's at-the-market offering of common stock. | 2023-09-19 | View |
| Lincoln Park Capital Fund, LLC | — | investor | Committed to purchase up to $20.0 million of Kintara Therapeutics, Inc. common stock under a purchase agreement. | 2022-08-03 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-24 | Financial Obligation; Exhibits | View | |
| 2026-09-17 | Officer/Director Change; Exhibits | View | |
| 2026-09-17 | Financial Obligation; Exhibits | View | |
| 2026-09-16 | Officer/Director Change; Exhibits | View | |
| 2026-09-04 | Financial Obligation; Exhibits | View | |
| 2026-08-21 | Financial Obligation; Exhibits | View | |
| 2026-08-19 | Unregistered Equity Sales; Shareholder Vote; Exhibits | View | |
| 2026-08-14 | Earnings Release; Exhibits | View | |
| 2026-08-13 | Financial Obligation; Exhibits | View | |
| 2026-07-29 | Financial Obligation; Exhibits | View | |
| 2026-07-07 | Financial Obligation; Exhibits | View | |
| 2026-06-17 | Other Events | View | |
| 2026-05-29 | Financial Obligation; Exhibits | View | |
| 2026-05-15 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-30 | Other Events; Exhibits | View | |
| 2026-04-22 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-04-08 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-04-01 | Earnings Release; Exhibits | View | |
| 2026-01-30 | Notice of Delisting or Transfer | View | |
| 2025-12-10 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR